Evaluation Of Relationship Between Endoscopic Activity Index and Inflammatory Indicators Such as Fecal Calprotectin, C-Reactive Protein to Albumin Ratio, Neutrophil to Lymphocyte Ratio, Platelet to Lymphocyte Ratio in Ulcerative Colitis Patients:

Tarang  Taghvaei; Seyyed Abbas Hashemi; Iradj  Maleki; Mahboobe  Ebrahimi; Arash  Kazemi; Reyhane   Ebrahimi Shahabi; Jamshid  Yazdani Charati

doi:10.5937/jomb0-58955

Tarang Taghvaei Gut and Liver Research Center, Mazandaran University of Medical Sciences, Sari, Iran
Seyyed Abbas Hashemi Gut and Liver Research Center, Mazandaran University of Medical Sciences, Sari, Iran
Iradj Maleki Gut and Liver Research Center, Mazandaran University of Medical Sciences, Sari, Iran
Mahboobe Ebrahimi Gut and Liver Research Center, Mazandaran University of Medical Sciences, Sari, Iran
Arash Kazemi Gut and Liver Research Center, Mazandaran University of Medical Sciences, Sari, Iran
Reyhane Ebrahimi Shahabi Gut and Liver Research Center, Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran, Department of Microbiology, Ayatollah Amoli Branch, Islamic Azad University, Amol, Iran
Jamshid Yazdani Charati Department of Biostatistics, Health Sciences Research Center, Addiction Institute, Mazandaran University of Medical Sciences, Sari, Iran

DOI: https://doi.org/10.5937/jomb0-58955

Ključne reči: .

Sažetak

-

Reference

1. Mehdizadeh S, Chen G, Enayati PJ, Cheng DW, Han NJ, Shaye OA, Ippoliti A, Vasiliauskas EA, Lo SK, Papadakis KA. Diagnostic yield of capsule endoscopy in ulcerative colitis and inflammatory bowel disease of unclassified type (IBDU). Endoscopy. 2008 Jan;40(01):30-5.
2. Romberg-Camps MJ, Hesselink-van de Kruijs MA, Schouten LJ, Dagnelie PC, Limonard CB, Kester AD, Bos LP, Goedhard J, Hameeteman WH, Wolters FL, Russel MG. Inflammatory bowel disease in South Limburg (the Netherlands) 1991–2002: incidence, diagnostic delay, and seasonal variations in onset of symptoms. Journal of Crohn's and Colitis. 2009 Jun 1;3(2):115-24.
3. Le Berre C, Danese S, Peyrin-Biroulet L. Can we change the natural course of inflammatory bowel disease?. Therapeutic advances in gastroenterology. 2023 Apr;16:17562848231163118.
4. Le Berre C, Honap S, Peyrin-Biroulet L. Ulcerative colitis. Lancet. 2023 Aug 12;402(10401):571-584. doi: 10.1016/S0140-6736(23)00966-2. PMID: 37573077.
5. Choi CH, Jung SA, Lee BI, Lee KM, Kim JS, Han DS. Diagnostic guideline of ulcerative colitis. The Korean journal of gastroenterology= Taehan Sohwagi Hakhoe chi. 2009 Mar 1;53(3):145-60.
6. Waye JD. The role of colonoscopy in the differential diagnosis of inflammatory bowel disease. Gastrointestinal endoscopy. 1977 Feb 1;23(3):150-4.
7. Jalan KN, Walker RJ, Sircus W, McManus JP, Prescott RJ, Card WI. Pseudopolyposis in ulcerative colitis. The Lancet. 1969 Sep 13;294(7620):555-9.
8. D’haens G, Sandborn WJ, Feagan BG, Geboes K, Hanauer SB, Irvine EJ, Lémann M, Marteau P, Rutgeerts P, Schölmerich J, Sutherland LR. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology. 2007 Feb 1;132(2):763-86.
9. Schoepfer A, Beglinger C, Straumann A, Trummler M, Renzulli P, Seibold F. Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes. Inflamm Bowel Dis. 2009;15(12):1851–8.
10. Walsham N, Sherwood R. Fecal calprotectin in inflammatory bowel disease. Clin Exp Gastroenterol. 2016;9:21–9.
11. Maréchal C, Aimone-Gastin I, Baumann C, Dirrenberger B, Guéant J, Peyrin-Biroulet L. Compliance with the faecal calprotectin test in patients with inflammatory bowel disease. United Eur Gastroenterol J. 2017;5(5):702–7.
12. Qin G, Tu J, Liu L, Luo L, Wu J, Tao L, Zhang C, Geng X, Chen X, Ai X, et al. Serum albumin and C-reactive protein/albumin ratio are useful biomarkers of Crohn’s disease activity. Med Sci Monit. 2016;22:4393–400.
13. Puolanne A-M, Kolho K-L, Alfthan H, Ristimäki A, Mustonen H, Färkkilä M. Rapid fecal calprotectin test and symptom index in monitoring the disease activity in colonic inflammatory bowel disease. Digestive diseases and sciences. 2017;62:3123-30.
14. Sarsu SB, Erbagci AB, Ulusal H, Karakus SC, Bulbul ÖG. The place of calprotectin, lactoferrin, and high-mobility group box 1 protein on diagnosis of acute appendicitis with children. Indian Journal of Surgery. 2017;79:131-6.
15. Ye L, Cheng W, Chen B-q, Lan X, Wang S-d, Wu X-c, et al. Levels of faecal calprotectin and magnetic resonance enterocolonography correlate with severity of small bowel Crohn’s disease: a retrospective cohort study. Scientific Reports. 2017;7(1):1970
16. Ma L, Pang X, Ji G, Ma X, Li J, Chang Y, Ma C. Application of the neutrophil to lymphocyte ratio in the diagnosis and activity determination of ulcerative colitis: A meta-analysis and systematic review. Medicine. 2021 Oct 22;100(42):e27551.
17. Hu X, Li J, Sun Y, et al. Combined use of CDAI and blood indices for assessing endoscopic activity in ileocolic Crohn's disease. BMC Gastroenterol. 2023;23(1):337. doi:10.1186/s12876-023-02968-0
18. Danese S, Cde L MC, Fiocchi C. Platelets in inflammatory bowel disease: clinical, pathogenic, and therapeutic implications. Am J Gastroenterol. 2004;99(5):938-945. doi:10.1111/j.1572-0241.2004.04129.x
19. Hisamatsu T, Kanai T, Mikami Y, Yoneno K, Matsuoka K, Hibi T. Immune aspects of the pathogenesis of inflammatory bowel disease. Pharmacol Ther. 2013;137(3):283-297. doi:10.1016/j.pharmthera.2012.10.008
20. Sayar S, Kurbuz K, Kahraman R, Caliskan Z, Atalay R, Ozturk O, Doganay HL, Ozdil K. A practical marker to determining acute severe ulcerative colitis: CRP/albumin ratio. Northern clinics of Istanbul. 2020 Jan 1;7(1).
21. Liu D, Saikam V, Skrada KA, Merlin D, Iyer SS. Inflammatory bowel disease biomarkers. Med Res Rev. 2022;42(5):1856-1887. doi:10.1002/med.21893
22. Gibson DJ, Hartery K, Doherty J, Nolan J, Keegan D, Byrne K, Martin ST, Buckley M, Sheridan J, Horgan G, Mulcahy HE. CRP/albumin ratio: an early predictor of steroid responsiveness in acute severe ulcerative colitis. Journal of clinical gastroenterology. 2018 Jul 1;52(6):e48-52.
23. Chen YH, Wang L, Feng SY, Cai WM, Chen XF, Huang ZM. The relationship between C‐reactive protein/albumin ratio and disease activity in patients with inflammatory bowel disease. Gastroenterology research and practice. 2020;2020(1):3467419.
24. Dulai PS, Feagan BG, Sands BE, Chen J, Lasch K, Lirio RA. Prognostic Value of Fecal Calprotectin to Inform Treat-to-Target Monitoring in Ulcerative Colitis. Clinical Gastroenterology and Hepatology. 2023;21(2):456-66.e7.
25. Hu T, Zhang Z, Song F, Zhang W, Yang J. Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin vs. Fecal Immunochemical Test: A Systematic Review and Meta-analysis. Turk J Gastroenterol. 2023;34(9):892-901.
26. Croft A, Lord A, Radford-Smith G. Markers of Systemic Inflammation in Acute Attacks of Ulcerative Colitis: What Level of C-reactive Protein Constitutes Severe Colitis? Journal of Crohn's and Colitis. 2022;16(7):1089-96
27. Rubio-Acosta F, Moctezuma-Velázquez P, Castro-Romero E, Uscanga-Domínguez L, Yamamoto-Furusho K, Moctezuma-Velázquez C, et al. The neutrophil-lymphocyte ratio as a predictor of steroid response in patients with severe ulcerative colitis: a retrospective cohort study. Revista espanola de enfermedades digestivas. 2023;115(4):197-9.
28. Celikbilek M, Dogan S, Ozbakır O, Zararsız G, Kücük H, Gürsoy S, Yurci A, Güven K, Yücesoy M. Neutrophil–lymphocyte ratio as a predictor of disease severity in ulcerative colitis. Journal of clinical laboratory analysis. 2013 Jan;27(1):72-6.
29. Ge ZB, Zhang XY, Zhang CM, Xu TT, Li SY, Wei MX, Ding XY, Bai CJ, Wang H, Zhou HH, Wang MY. C‐Reactive Protein Is Not the Driver Factor in Ulcerative Colitis. Gastroenterology Research and Practice. 2024;2024(1):1386147.
30. Yeşil A, Şenateş E, Erdem ED, Demirtunç R, Övünç AO. Red cell distribution width: a novel marker of activity in inflammatory bowel disease. Gut and liver. 2011 Nov 21;5(4):460.